Cargando…
A Genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers
BACKGROUND: Genetic as well as epigenetic alterations are a hallmark of both epithelial and haematological malignancies. High throughput screens are required to identify epigenetic markers that can be useful for diagnostic and prognostic purposes across malignancies. RESULTS: Here we report for the...
Autores principales: | Dunwell, Thomas, Hesson, Luke, Rauch, Tibor A, Wang, Lihui, Clark, Richard E, Dallol, Ashraf, Gentle, Dean, Catchpoole, Daniel, Maher, Eamonn R, Pfeifer, Gerd P, Latif, Farida |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838813/ https://www.ncbi.nlm.nih.gov/pubmed/20184741 http://dx.doi.org/10.1186/1476-4598-9-44 |
Ejemplares similares
-
The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
por: Hesson, Luke B, et al.
Publicado: (2009) -
Identification of 5 novel genes methylated in breast and other epithelial cancers
por: Hill, Victoria K, et al.
Publicado: (2010) -
Identification of Candidate Tumour Suppressor Genes Frequently Methylated in Renal Cell Carcinoma
por: Morris, Mark R., et al.
Publicado: (2010) -
RASSF2 can suppress the growth of breast cancer cell lines and is epigenetically inactivated in breast tumours
por: Cooper, WN, et al.
Publicado: (2008) -
Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastoma
por: Margetts, Caroline D E, et al.
Publicado: (2008)